112
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Bcl-XL Is the primary mediator of p21 protection against hyperoxia-induced cell death

&
Pages 82-91 | Received 22 Apr 2010, Accepted 02 Sep 2010, Published online: 04 Dec 2010

REFERENCES

  • Freeman BA, Crapo JD: Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem. 1981;256:10986–10992.
  • Pagano A, Barazzone-Argiroffo C: Alveolar cell death in hyperoxia-induced lung injury. Ann N Y Acad Sci. 2003; 1010: 405–416.
  • Mantell LL, Horowitz S, Davis JM, Kazzaz JA: Hyperoxia-induced cell death in the lung—the correlation of apoptosis, necrosis, and inflammation. Ann N Y Acad Sci. 1999; 887: 171–180.
  • Barazzone C, Horowitz S, Donati YR, Rodriguez I, Piguet PF: Oxygen toxicity in mouse lung: pathways to cell death. Am J Respir Cell Mol Biol. 1998; 19: 573–581.
  • Budinger GR, Tso M, McClintock DS, Dean DA, Sznajder JI, Chandel NS: Hyperoxia-induced apoptosis does not require mitochondrial reactive oxygen species and is regulated by Bcl-2 proteins. J Biol Chem. 2002; 277: 15654–15660.
  • Metrailler-Ruchonnet I, Pagano A, Carnesecchi S, Ody C, Donati Y, Barazzone Argiroffo C: Bcl-2 protects against hyperoxia-induced apoptosis through inhibition of the mitochondria-dependent pathway. Free Radic Biol Med. 2007; 42: 1062–1074.
  • Vitiello PF, Wu YC, Staversky RJ, O'Reilly MA: p21(Cip1) protects against oxidative stress by suppressing ER-dependent activation of mitochondrial death pathways. Free Radic Biol Med. 2009; 46: 33–41.
  • He CH, Waxman AB, Lee CG, Link H, Rabach ME, Ma B, Chen Q, Zhu Z, Zhong M, Nakayama K, Nakayama KI, Homer R, Elias JA: Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury. J Clin Invest. 2005; 115: 1039–1048.
  • Nyunoya T, Monick MM, Powers LS, Yarovinsky TO, Hunninghake GW: Macrophages survive hyperoxia via prolonged ERK activation due to phosphatase down-regulation. J Biol Chem. 2005; 280: 26295–26302.
  • Wang X, Ryter SW, Dai C, Tang ZL, Watkins SC, Yin XM, Song R, Choi AM: Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J Biol Chem. 2003; 278: 29184–29191.
  • Franek WR, Morrow DM, Zhu H, Vancurova I, Miskolci V, Darley-Usmar K, Simms HH, Mantell LL: NF-kappaB protects lung epithelium against hyperoxia-induced nonapoptotic cell death-oncosis. Free Radic Biol Med. 2004; 37: 1670–1679.
  • O'Reilly MA, Staversky RJ, Finkelstein JN, Keng PC: Activation of the G2 cell cycle checkpoint enhances survival of epithelial cells exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2003; 284: L368-L375.
  • Rancourt RC, Hayes DD, Chess PR, Keng PC, O'Reilly MA: Growth arrest in G1 protects against oxygen-induced DNA damage and cell death. J Cell Physiol. 2002; 193: 26–36.
  • Shenberger JS, Dixon PS: Oxygen induces S-phase growth arrest and increases p53 and p21(WAF1/CIP1) expression in human bronchial smooth-muscle cells. Am J Respir Cell Mol Biol. 1999; 21: 395–402.
  • Helt CE, Rancourt RC, Staversky RJ, O'Reilly MA: p53-dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity. Toxicol Sci. 2001; 63: 214–222.
  • Gehen SC, Staversky RJ, Bambara RA, Keng PC, O'Reilly MA: hSMG-1 and ATM sequentially and independently regulate the G(1) checkpoint during oxidative stress. Oncogene. 2008; 27: 4065–4074.
  • McGrath-Morrow SA, Cho C, Soutiere S, Mitzner W, Tuder R: The effect of neonatal hyperoxia on the lung of p21Waf1/Cip1/Sdi1-deficient mice. Am J Respir Cell Mol Biol. 2004; 30: 635–640.
  • Bissonnette N, Hunting DJ: p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene. 1998; 16: 3461–3469.
  • Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B: Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 1996; 10: 1945–1952.
  • Rancourt RC, Keng PC, Helt CE, O'Reilly MA: The role of p21(CIP1/WAF1) in growth of epithelial cells exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2001; 280: L617-L626.
  • Gorospe M, Wang X, Guyton KZ, Holbrook NJ: Protective role of p21(Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol Cell Biol. 1996; 16: 6654–6660.
  • Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S: Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 1999; 18: 1223–1234.
  • Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M: Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene. 1998; 17: 931–939.
  • Xu SQ, El-Deiry WS: p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4. Biochem Biophys Res Commun. 2000; 269: 179–190.
  • Vitiello PF, Staversky RJ, Gehen SC, Johnston CJ, Finkelstein JN, Wright TW, O'Reilly MA: P21Cip1 protection against hyperoxia requires Bcl-XL and is uncoupled from its ability to suppress growth. Am J Pathol. 2006; 168: 1838–1847.
  • Staversky RJ, Vitiello PF, Gehen SC, Helt CE, Rahman A, Keng PC, O'Reilly MA: p21(Cip1/Waf1/Sdi1) protects against hyperoxia by maintaining expression of Bcl-X(L). Free Radic Biol Med. 2006; 41: 601–609.
  • Vitiello PF, Staversky RJ, Keng PC, O'Reilly MA: PUMA inactivation protects against oxidative stress through p21/Bcl-XL inhibition of bax death. Free Radic Biol Med. 2008; 44: 367–374.
  • Helt CE, Staversky RJ, Lee YJ, Bambara RA, Keng PC, O'Reilly MA: The Cdk and PCNA domains on p21Cip1 both function to inhibit G1/S progression during hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2004; 286: L506-L513.
  • Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM, Huang DC: Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005; 19: 1294–1305.
  • O'Reilly MA, Staversky RJ, Huyck HL, Watkins RH, LoMonaco MB, D'Angio CT, Baggs RB, Maniscalco WM, Pryhuber GS: Bcl-2 family gene expression during severe hyperoxia induced lung injury. Lab Invest. 2000; 80: 1845–1854.
  • Kim YG, Kim HJ, Kim DS, Kim SD, Han WS, Kim KH, Chung JH, Park KC: Up-regulation and redistribution of Bax in ultraviolet B-irradiated melanocytes. Pigment Cell Res. 2000; 13: 352–357.
  • Isenmann S, Wahl C, Krajewski S, Reed JC, Bahr M: Up-regulation of Bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur J Neurosci. 1997; 9: 1763–1772.
  • Pearson AS, Spitz FR, Swisher SG, Kataoka M, Sarkiss MG, Meyn RE, McDonnell TJ, Cristiano RJ, Roth JA: Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells. Clin Cancer Res. 2000; 6: 887–890.
  • Chirakkal H, Leech SH, Brookes KE, Prais AL, Waby JS, Corfe BM: Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding. Oncogene. 2006; 25: 7192–7200.
  • Morrison DJ, English MA, Licht JD: WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. Cancer Res. 2005; 65: 8174–8182.
  • Shimazu T, Degenhardt K, Nur EKA, Zhang J, Yoshida T, Zhang Y, Mathew R, White E, Inouye M: NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition. Genes Dev. 2007; 21: 929–941.
  • Xu D, Perez RE, Ekekezie, II, Navarro A, Truog WE: Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death. Am J Physiol Lung Cell Mol Physiol. 2008; 294: L17-L23.
  • Germain M, Milburn J, Duronio V: MCL-1 inhibits BAX in the absence of MCL-1/BAX Interaction. J Biol Chem. 2008; 283: 6384–6392.
  • Zhou P, Qian L, Kozopas KM, Craig RW: Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood. 1997; 89: 630–643.
  • Vairo G, Soos TJ, Upton TM, Zalvide J, DeCaprio JA, Ewen ME, Koff A, Adams JM: Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation. Mol Cell Biol. 2000; 20: 4745–4753.
  • Greider C, Chattopadhyay A, Parkhurst C, Yang E: BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases. Oncogene. 2002; 21: 7765–7775.
  • Mei Y, Du W, Yang Y, Wu M: Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1. Oncogene. 2005; 24: 7224–7237.
  • Czabotar PE, Lee EF, van Delft MF, Day CL, Smith BJ, Huang DC, Fairlie WD, Hinds MG, Colman PM: Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci U S A. 2007; 104: 6217–6222.
  • Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 2000; 288: 1053–1058.
  • Ming L, Wang P, Bank A, Yu J, Zhang L: PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells. J Biol Chem. 2006; 281: 16034–16042.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.